Search research articles
Contact Us
Filters
Showing results (11-20 of 77) with videos related to
Page
of 8
Sort By:
Biomedical Optics Express
|
December 18, 2012
Surface plasmon resonance as detection tool for lipids lateral mobility in biomimetic membranes
Giancarlo Margheri, Riccardo D'Agostino, Lucia Becucci, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 5, 2018
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis
Anastasia Chillà, Francesca Margheri, Alessio Biagioni, et al.
Journal of Biological Engineering
|
May 10, 2019
Erratum: Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy
Alessio Biagioni, Anna Laurenzana, Francesca Margheri, et al.
Current Pharmaceutical Design
|
June 30, 2011
The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation
Mario Del Rosso, Francesca Margheri, Simona Serratì, et al.
Journal of Biological Engineering
|
December 22, 2018
Delivery systems of CRISPR/Cas9-based cancer gene therapy
Alessio Biagioni, Anna Laurenzana, Francesca Margheri, et al.
Cell Cycle (Georgetown, Tex.)
|
June 9, 2016
Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation
Silvia Peppicelli, Alessandra Toti, Elisa Giannoni, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 26, 2016
Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma
Elena Andreucci, Francesca Bianchini, Alessio Biagioni, et al.
Clinical & Experimental Metastasis
|
June 18, 2002
Multiple pathways of cell invasion are regulated by multiple families of serine proteases
Mario Del Rosso, Gabriella Fibbi, Marco Pucci, et al.
Journal of Cellular Physiology
|
September 5, 2002
Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential
Germana Dini, Silvia Funghini, Ewa Witort, et al.
Cancers
|
July 8, 2020
Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma
Anastasia Chillà, Francesca Margheri, Alessio Biagioni, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 77) with videos related to
Sort By:
Page
of 8
Biomedical Optics Express
|
December 18, 2012
Surface plasmon resonance as detection tool for lipids lateral mobility in biomimetic membranes
Giancarlo Margheri, Riccardo D'Agostino, Lucia Becucci, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 5, 2018
Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis
Anastasia Chillà, Francesca Margheri, Alessio Biagioni, et al.
Journal of Biological Engineering
|
May 10, 2019
Erratum: Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy
Alessio Biagioni, Anna Laurenzana, Francesca Margheri, et al.
Current Pharmaceutical Design
|
June 30, 2011
The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation
Mario Del Rosso, Francesca Margheri, Simona Serratì, et al.
Journal of Biological Engineering
|
December 22, 2018
Delivery systems of CRISPR/Cas9-based cancer gene therapy
Alessio Biagioni, Anna Laurenzana, Francesca Margheri, et al.
Cell Cycle (Georgetown, Tex.)
|
June 9, 2016
Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation
Silvia Peppicelli, Alessandra Toti, Elisa Giannoni, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
August 26, 2016
Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma
Elena Andreucci, Francesca Bianchini, Alessio Biagioni, et al.
Clinical & Experimental Metastasis
|
June 18, 2002
Multiple pathways of cell invasion are regulated by multiple families of serine proteases
Mario Del Rosso, Gabriella Fibbi, Marco Pucci, et al.
Journal of Cellular Physiology
|
September 5, 2002
Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential
Germana Dini, Silvia Funghini, Ewa Witort, et al.
Cancers
|
July 8, 2020
Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma
Anastasia Chillà, Francesca Margheri, Alessio Biagioni, et al.
Page
of 8